UK health regulator has made eight observations at Alkem Laboratories’ manufacturing plant at Taloja, Maharashtra. The Medicines and Healthcare Products Regulator Agency (UKMHRA) had conducted an inspection at the company's facility at Taloja earlier this month with respect to marketing authorisation applications made by the company to the EU countries. The company has received inspection report from the UKMHRA on March 30 where 8 observations have been made by the regulator.
Alkem Laboratories is engaged in manufacturing and distributing pharmaceuticals products. It offers active pharmaceutical ingredient (API), generic, branded and nutraceuticals products under the brand name Clavm, Pan20, Pan40, Sumo. The firm also provides formulations for acute and chronic therapeutic focusing on anti-infective, gastrointestinal, cardiovascular, anti-diabetic, and pain management segments.
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1936.00 |
| Dr. Reddys Labs. | 1245.65 |
| Cipla | 1438.10 |
| Zydus Lifesciences | 1150.40 |
| Lupin | 2495.00 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: